title: Current controversies in prenatal diagnosis 2: for those women screened by NIPT using cell free DNA, maternal serum markers are obsolete.
authors.affiliation: Genetic Institute, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.
authors.forename: Yuval
authors.initials: Y
authors.lastname: Yaron
authors.affiliation: Royal Prince Alfred Hospital Sydney, University of Sydney, Sydney, NSW, Australia.
authors.forename: Jon
authors.initials: J
authors.lastname: Hyett
authors.affiliation: Department of Medical Genetics, University of British Columbia, Vancouver, Canada.
authors.forename: Sylvie
authors.initials: S
authors.lastname: Langlois
mesh_terms: D000782:Aneuploidy; D015415:Biomarkers / Q000032:analysis*; D000013:Congenital Abnormalities / Q000175:diagnosis / Q000196:embryology; D004247:DNA / Q000097:blood*; D016640:Diabetes, Gestational / Q000175:diagnosis; D005260:Female; D005865:Gestational Age; D006801:Humans; D048208:Nuchal Translucency Measurement; D011225:Pre-Eclampsia / Q000175:diagnosis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis; D011296:Prenatal Diagnosis / Q000379:methods*; D012307:Risk Factors
chemical_list: D015415:Biomarkers; D004247:DNA